U.S. advances in the use of nuclear accelerators to fight cancer are being tempered by concerns about the high cost of such equipment with uncertain benefits.
U.S. advances in the use of nuclear accelerators to fight cancer are being tempered by concerns about the high cost of such equipment with uncertain benefits.